Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-27 11:35 am Purchase |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
Lamond David | 2,048,938 6.900% |
93,773 (+4.80%) |
Filing History |
| 2021-03-25 4:17 pm Sale |
2021-03-16 | 13G | Quince Therapeutics, Inc. QNCX |
PFIZER INC PFE |
2,056,377 7.000% |
-86,995 (-4.06%) |
Filing History |
| 2021-03-10 2:10 pm Purchase |
2021-03-10 | 13G | Quince Therapeutics, Inc. QNCX |
Capital World Investors | 3,170,731 10.700% |
560,494 (+21.47%) |
Filing History |
| 2021-02-16 2:24 pm Unchanged |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 2,580,455 8.700% |
0 (Unchanged) |
Filing History |
| 2021-02-16 1:57 pm Purchase |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital International Investors | 2,580,455 8.700% |
2,580,455 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital Research Global Investors | 2,605,753 8.800% |
162,839 (+6.67%) |
Filing History |
| 2021-02-16 12:34 pm Purchase |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital World Investors | 2,610,237 8.800% |
2,610,237 (New Position) |
Filing History |
| 2021-02-12 5:37 pm Sale |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
PFIZER INC PFE |
2,143,372 7.300% |
-1,106,601 (-34.05%) |
Filing History |
| 2021-02-01 4:25 pm Purchase |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
EPQ LLC CTYM PS | 2,863,096 9.710% |
36,300 (+1.28%) |
Filing History |
| 2021-01-28 5:57 pm Sale |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
TAKEDA PHARMACEUTICAL CO LTD | 87,258 0.300% |
-2,592,544 (-96.74%) |
Filing History |